1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-5329
  5. NDC Package Code: 50090-5329-0 Cilostazol

NDC Package 50090-5329-0 Cilostazol

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50090-5329-0
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
50090-5329
Proprietary Name:
Cilostazol
Non-Proprietary Name:
Cilostazol
Substance Name:
Cilostazol
Usage Information:
Cilostazol is used to improve the symptoms of a certain blood flow problem in the legs (intermittent claudication). Cilostazol can decrease the muscle pain/cramps that occur during exercise/walking. Claudication pain is caused by too little oxygen getting to the muscles. Cilostazol can increase blood flow and the amount of oxygen that gets to the muscles. Cilostazol is an antiplatelet drug and a vasodilator. It works by stopping blood cells called platelets from sticking together and prevents them from forming harmful clots. It also widens blood vessels in the legs. Cilostazol helps the blood to move more easily and keeps blood flowing smoothly in your body.
11-Digit NDC Billing Format:
50090532900
NDC to RxNorm Crosswalk:
  • RxCUI: 242462 - cilostazol 50 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    A-s Medication Solutions
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • CILOSTAZOL 50 mg/1
    • Pharmacologic Class(es):
  • Phosphodiesterase 3 Inhibitor - [EPC] (Established Pharmacologic Class)
  • Phosphodiesterase 3 Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA077027
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-24-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50090-5329-0?

    The NDC Packaged Code 50090-5329-0 is assigned to a package of 30 tablet in 1 bottle of Cilostazol, a human prescription drug labeled by A-s Medication Solutions. The product's dosage form is tablet and is administered via oral form.

    Is NDC 50090-5329 included in the NDC Directory?

    Yes, Cilostazol with product code 50090-5329 is active and included in the NDC Directory. The product was first marketed by A-s Medication Solutions on April 24, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 50090-5329-0?

    The 11-digit format is 50090532900. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-150090-5329-05-4-250090-5329-00